MTL Cannabis Corp. — Investor Relations & Filings
Filings indexed
643
across all filing types
Latest filing
2026-04-29
Regulatory Filings
Country
CA
Canada
Listing
CSE
MTLC
MTL Cannabis Corp. is a producer and distributor of cannabis products, recognized as a leader in the premium craft segment. The company operates as a "flower first" entity, specializing in the cultivation of high-THC, terpene-rich, indoor-grown cannabis flower and precision-rolled pre-rolls for the recreational market. MTL focuses on providing quality and accessibility to discerning consumers. Furthermore, the company maintains a significant presence in the medical cannabis sector, engaging in domestic distribution through subsidiaries and exporting branded products to international medical markets, including Australia.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Decision Document / Order for Application - English.pdf | 2026-04-29 | English | |
| Other securityholders documents - English.pdf | 2026-03-17 | English | |
| Notice.pdf | 2026-03-16 | English | |
| Material change report - English.pdf | 2026-03-16 | English | |
| News release - English.pdf | 2026-03-16 | English | |
| News release - English.pdf | 2026-02-27 | English |
Browse filings by year
24 years- 2026 27 filings
- 2025 58 filings
- 2024 32 filings
- 2023 62 filings
- 2022 47 filings
- 2021 57 filings
- 2020 76 filings
- 2019 52 filings
- 2018 68 filings
- 2017 50 filings
- 2016 41 filings
- 2015 50 filings
- 2012 2 filings
- 2011 6 filings
- 2010 1 filing
- 2009 1 filing
- 2008 2 filings
- 2007 1 filing
- 2006 3 filings
- 2005 3 filings
- 2001 1 filing
- 2000 1 filing
- 1998 1 filing
- 1997 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47145945 | Decision Document / Order for Application - English.pdf | 2026-04-29 | English | ||
| 47145949 | Other securityholders documents - English.pdf | 2026-03-17 | English | ||
| 47145953 | Notice.pdf | 2026-03-16 | English | ||
| 47145999 | Material change report - English.pdf | 2026-03-16 | English | ||
| 47146007 | News release - English.pdf | 2026-03-16 | English | ||
| 47146013 | News release - English.pdf | 2026-02-27 | English | ||
| 47146232 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2026-02-27 | English | ||
| 47146422 | Interim MD&A - English.pdf | 2026-02-27 | English | ||
| 47146425 | Interim financial statements/report – English.pdf | 2026-02-27 | English | ||
| 47146429 | News release - French.pdf | 2026-02-25 | English | ||
| 47146458 | News release - English.pdf | 2026-02-23 | English | ||
| 47146461 | News release - French.pdf | 2026-02-23 | English | ||
| 47146465 | News release - English.pdf | 2026-02-18 | English | ||
| 47146523 | News release - French.pdf | 2026-02-12 | English | ||
| 47146527 | News release - English.pdf | 2026-02-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
MTL Cannabis Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44162/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44162 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44162 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44162 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44162}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MTL Cannabis Corp. (id: 44162)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.